您的位置：首页 > 产品中心 > 100276-03-7， BAY R3401
BAY R3401
产品别名
100276-03-7
BAY R3401
4-(2-Chlorophenyl)-1-ethyl-2-methyl-5-oxo-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylic acid isopropyl ester
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C20H22ClNO4 |
| Molecular weight | 375.85 |
| MDL number | MFCD08705409 |
| PubChem Substance ID【PubChem化学物质编号】 | 24891741 |
| NACRES | NA.77 |
| Biochem/physiol Actions【生化/生理作用】 | BAY R3401 is a glycogen phosphorylase inhibitor. The racemic prodrug, BAY R3401, suppresses hepatic glycogenolysis. BAY W1807, the active metabolite of BAY R3401, inhibits muscle glycogen phosphorylase a and b. It has been investigated that the metabolites of BAY R3401 suppress hepatic glycogenolysis by allosteric inhibition and dephosphorylation of phosphorylase a. |
| Features and Benefits【特点和优势】 | This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | solid |
| color【颜色】 | white |
| solubility【溶解性】 | DMSO: 15 mg/mL |
| originator【创始人】 | Bayer |
| storage temp.【储存温度】 | 2-8℃ |
| SMILES string | CCN1C(C)=C(C(c2ccccc2Cl)C3=C1COC3=O)C(=O)OC(C)C |
| InChI | 1S/C20H22ClNO4/c1-5-22-12(4)16(20(24)26-11(2)3)17(13-8-6-7-9-14(13)21)18-15(22)10-25-19(18)23/h6-9,11,17H,5,10H2,1-4H3 |
| InChI key | NPUSXSOBPNHOPH-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle Light sensitive; store in amber vials. |
安全信息
| Pictograms【象形图】 | GHS07 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
| Personal Protective Equipment【个人防护装备】 | dust mask type N95 (US), Eyeshields, Gloves |
